crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in … the US pharmaceutical industry. We estimate the effect of patent length and scope on generic entry prior to the expiration … of new drug patents using two quasi-experimental approaches: one based on changes in patent laws and another on the …

prevention of COVID-19. The aim of the report is to support national patent offices and interested parties in developing … countries with information that can serve as guidance for the examination of the claims contained in relevant patents or patent … applications. The antibody combination considered for the patent analysis in this paper are Casirivimab and Imdevimab. The vaccines …

look at the development that has taken place in other jurisdictions and adapt the patent law to local conditions when …

finds that introduction of product patent for pharmaceuticals in the patent law has a positive effect on launch likelihood … pharmaceuticals are launched sooner than non-innovative ones, irrespective of the patent regime in the local market. Using a panel …This WTO working paper studies availability and affordability of new and innovative pharmaceuticals in a post-TRIPS era …

This working paper provides a statistical analysis of 74 patent families which cover subject matter relevant to ten … based on VaxPaL, a COVID-19 vaccines patent database developed by the Medicines Patent Pool (MPP). Through the detailed … examination of patent applicants, filing dates, and offices of first and subsequent filing, the paper identifies patterns and …

. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for … to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries …This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of …

the functioning of the patent system, innovation researchers have been surprisingly silent on the topic. This paper … sets of chemical (sub)structures. As genus claims, they allow a vast number of compounds to be claimed in a patent … are used in patent documents in the pharmaceutical industry and how they affect important outcomes in the patent …